Monte Rosa Therapeutics Inc

GLUENASDAQ · US

Holders

REDUCEDT+7
Bowen Matthew
Monte Rosa Therapeutics Inc · NASDAQ
−13 sh · $137
Filed 6 Oct 2026SEC Form 4view source
DISCLOSEDQuarterly
Duquesne Family Office
Monte Rosa Therapeutics Inc · NASDAQ
297,600 sh · $7.2M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Monte Rosa Therapeutics Inc · NASDAQ
19,300 sh · $317.5K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Monte Rosa Therapeutics Inc · NASDAQ
379,100 sh · $6.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Monte Rosa Therapeutics Inc · NASDAQ
2,360,093 sh · $8.8M
Filed 30 Jun 2024SEC 13Fview source